<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>New research shows dogs with MMVD live longer with pimobendan</title><link>/b/veterinary-news/posts/new-research-shows-dogs-with-mmvd-live-longer-with-pimobendan</link><description> Boehringer Ingelheim has released details of research presented at the 29th World Veterinary Congress which shows dogs with congestive heart failure (CHF) due to myxomatous mitral valve disease (MMVD) live longer when treated with pimobendan (Vetmedin</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>